Medtronic plc (FRA:2M6)

Market Cap	111.10B +4.4%
Revenue (ttm)	29.88B +5.3%
Net Income	4.10B +11.1%
EPS	3.17 +13.0%
Shares Out	n/a
PE Ratio	27.13
Forward PE	17.55
Dividend	2.47 (2.93%)
Ex-Dividend Date	Dec 26, 2025

Volume	602
Average Volume	1,152
Open	84.58
Previous Close	84.07
Day's Range	84.09 - 86.75
52-Week Range	68.50 - 91.45
Beta	n/a
RSI	58.59
Earnings Date	Feb 17, 2026

About Medtronic

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1949
• Employees: 95,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2M6

Financial Performance

In fiscal year 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial numbers in USD